.With early period 1 information right now out in the wild, metabolic ailment attire Metsera is actu...
.Rivus Pharmaceuticals has unveiled the data behind its own stage 2 excessive weight win in cardiac ...
.Bristol Myers Squibb is actually paying for Prime Medication $110 million upfront to create reagent...
.Novartis has actually tattooed a deal likely worth much more than $1 billion along with Flagship-fo...
.Recently debuted Metsera is unfolding some period 1 information for its own GLP-1 receptor agonist,...
.In the middle of the hereditary medications branches race, Front runner Pioneering is actually unve...
.BioAge Labs is considering all around $180 million in preliminary proceeds coming from an IPO and a...
.A try by Merck & Co. to open the microsatellite stable (MSS) metastatic intestines cancer cells ...
.Spain-based Asabys Allies has actually shut a fund of 180 million euros ($ 200 million), loan that ...
.BioAge Labs is actually producing practically $200 million by means of its Nasdaq IPO today, with t...